Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

CerTest VIASURE SARS-CoV-2 Real Time PCR Detection Kit

Products are for professional/laboratory use only.  CerTest VIASURE SARS-CoV-2 Real Time PCR Detection Kit is designed for the specific identification and differentiation of the New Coronavirus (SARS-CoV-2) in respiratory samples from patients with signs and symptoms of COVID-19.

This diagnostic kit is for professional use only, available with CE marking, and presents all the advantages offered by VIASURE tests.

Advantages of VIASURE tests:

  • Each well contains complete master mix for Real-Time PCR assay including internal control
  • Lyophilized and stabilized format
  • Same thermal protocol for all VIASURE kits (approximately 2 hours)
  • Ready and easy-to-use kits
  • Transport and storage at room temperature whilst maintaining product stability and viability
  • Shelf life 24-months for all VIASURE kits
  • Storage at room temperature
  • Available for IVD use 

 


View the CerTest SARS-CoV-2 Insert Sheet

Download Insert Sheet >

View the full CerTest VIASURE Product Catalogue

Download Catalogue >

Request a quote

Contact Us Now >

 

 

 



Request a Quote

Request Quote

Recent Posts

Fungal Infection – Assays and Controls*

IMMY | Vircell IMMY’s rapid fungal assays and Vircell’s external controls deliver reliable, room temperature diagnostics with built-in quality assurance for streamlined serology workflows. Vircell…

Read full article

Vircell – VirClia Extraction Tube

Discover Vircell’s VirClia Extraction Tube, an innovative pre-dispensed tube featuring a one-step filtering process that eliminates the need for centrifugation, thereby significantly simplifying the pre-analytical…

Read full article

Advancing Sepsis Diagnostics—Journal of Clinical Medicine (JCM), Honors SeptiCyte RAPID* Study

  Immunexpress are delighted to announce that the study, “Validation of SeptiCyte® RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation,” has been selected as an Editor’s Choice Paper for 2024 by the Journal of Clinical Medicine (JCM) MDPI Editorial Team. This honour…

Read full article